Product Reports Resources Pricing Login Book a demo

Enovis

Health Tech & Medtech · Wilmington, United States · Founded 1995 · IPO 2008

Medical technology firm dedicated to creating clinically distinct solutions

Valuation $3.06B
Revenue $2.35B
EBITDA $430M

Talent graph

Enovis's talent

Book a demo to see the people
Employees mapped 3,691 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Where Enovis has talent and traffic

Workforce by country
34 countries with
team presence
🇺🇸 United States58.2%
🇮🇹 Italy8.9%
🇲🇽 Mexico8.5%
🇨🇭 Switzerland3.3%
🇬🇧 United Kingdom3.3%
Top 5 of 34 shown
Web traffic by country
94K monthly visits
across markets
🇺🇸 United States41%
🇬🇧 United Kingdom8.4%
🇨🇦 Canada6%
🇦🇺 Australia5.5%
🇩🇪 Germany5.2%
Top 5 markets shown

Patent intelligence

$124M patent portfolio · 127 active families

Estimated portfolio value
$124M
4.1% of market cap · 11.9× larger than top peer Hinge Health ($10M)
127 active patent families
Where Enovis innovates Biomedical engineeringHinge angleKnee bracesMechanical engineeringPhysical medicine and rehabilitation

Where Enovis concentrates vs peers

Each axis is a top-10 topic across Enovis and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Enovis's 7 investments and acquisitions.

Every disclosed deal where Enovis appeared as a backer or acquirer, 2007–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Enovis's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Enovis deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Enovis's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        What the market is saying about Enovis

        An AI-synthesized read of the highest-engagement posts about Enovis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Enovis on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.